[1] Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368(10): 914-923. [2] Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368(10):904-913. [3] Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med, 2013, 368(10):893-903. [4] Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372(1):11-20. [5] Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372(11):1009-1018. [6] Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372 (11): 1019-1030. [7] Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015, 372(24): 2285-2295. [8] Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372(24):2296-2306. [9] 中国卒中学会, 中国卒中学会神经介入分会, 中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2015[J]. 中国卒中杂志, 2015, 10(7):590-606. [10] Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/ American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(10):3020-3035. [11] Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon- expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial[J]. JAMA, 2015, 313(12):1240-1248. [12] Compter A, van der Worp HB, Schonewille WJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial[J]. Lancet Neurol, 2015, 14(6):606-614. [13] Miao Z, Zhang Y, Shuai J, et al. Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China[J]. Stroke, 2015,46(10):2822-2829. [14] Huang X, Cheripelli BK, Lloyd SM, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study[J]. Lancet Neurol, 2015, 14(4):368-376. [15] Coutts SB, Dubuc V, Mandzia J, et al. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion[J]. Stroke, 2015, 46(3):769-774. [16] Albers GW, von Kummer R, Truelsen T, et al. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial[J]. Lancet Neurol, 2015, 14(6): 575-584. [17] Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke[J]. N Engl J Med, 2015, 372(6):528-536. [18] 胡大一, 徐希平. 有效控制“H型”高血压预防卒中的新思路[J]. 中华内科杂志, 2008, 47(12):976-977. [19] Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial[J]. JAMA, 2015, 313(13):1325-1335. [20] CADISS trial investigators, Markus HS, Hayter E, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial[J]. Lancet Neurol, 2015, 14(4):361-367. [21] Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(7):2032-2060. [22] Torbey MT, B sel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine[J]. Neurocrit Care, 2015, 22(1):146-164. [23] Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group[J]. Stroke, 2015, 46(8):2335-2340. [24] Harris D, Hall C, Lobay K, et al. Canadian Association of Emergency Physicians position statement on acute ischemic stroke[J]. CJEM, 2015, 17(2):217-226. [25] Eskes GA, Lanct t KL, Herrmann N, et al. Canadian stroke best practice recommendations: mood, aognition and fatigue following stroke practice guidelines, update 2015[J]. Int J Stroke, 2015, 10(7):1130-1140. [26] Jung KH, Yu KH, Kim YD, et al. Antithrombotic management of patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack: executive summary of the Korean clinical practice guidelines for stroke[J]. J Stroke, 2015, 17(2):210-215. [27] Middleton S, Grimley R, Alexandrov AW. Triage, treatment, and transfer: evidence-based clinical practice recommendations and models of nursing care for the first 72 hours of admission to hospital for acute stroke[J]. Stroke, 2015, 46(2):e18-25. [28] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4):246-257. [29] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J]. 中华神经科杂志, 2015, 48(4):258-273. [30] 中华医学会神经病学分会, 中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组. 中国急性缺血性脑卒中早期血管内介入诊疗指南[J]. 中华神经科杂志, 2015, 48(5):356-361. [31] 国家卫生和计划生育委员会, 神经内科医疗质量控制中心. 中国卒中中心建设指南[J]. 中国卒中杂志, 2015, 10(6):499-507. [32] 中华预防医学会卒中预防与控制专业委员会介入学组. 缺血性脑血管病介入治疗抗血小板策略中国专家共识[J]. 中华医学杂志, 2015, 95(11):803-809. [33] 中华预防医学会卒中预防与控制专业委员会脑血管病介入学组. 症状性动脉粥样硬化性椎动脉起始部狭窄血管内治疗中国专家共识[J]. 中华医学杂志, 2015, 95(9):648-653. |